Medicine and Dentistry
Acute Myeloid Leukemia
100%
Karyotype
66%
Acute Myelogenous Leukemia
44%
De Novo Acute Myeloid Leukemia
44%
Retrospective Study
44%
MDS1 and EVI1 Complex Locus Protein
44%
Chronic Myelogenous Leukemia
44%
Reduced Intensity Conditioning
44%
Droplet Digital Polymerase Chain Reaction
44%
Minimal Residual Disease
34%
Real-Time Polymerase Chain Reaction
24%
Comparative Genomic Hybridization
22%
Chronic Myelogenous Leukemia
14%
Laboratory Test
14%
Tumor Suppressor Gene
11%
Leukemogenesis
11%
Metaphase
11%
Chromosome Aberration
11%
High Risk Population
11%
Zinc Finger Protein
11%
Chromosome 8
11%
Gene Dosage
11%
NPM1
9%
Hematopoiesis
9%
False Positive Result
9%
Fanconi Anemia
8%
Lymphopoiesis
8%
Biochemistry, Genetics and Molecular Biology
Myeloid
88%
Karyotype
66%
MicroRNA
44%
Retrospective Study
44%
DNA Helix
44%
DNA Topoisomerase
44%
Cre Recombinase
44%
Topoisomerase
44%
MDS1 and EVI1 Complex Locus Protein
44%
Cytogenetics
44%
LYL1
29%
Comparative Genomic Hybridization
22%
Metaphase
22%
High Risk Population
22%
Chromosomal Abnormalities
22%
Tumor Suppressor Gene
11%
Gene Dosage
11%
Chromosome 8
11%
Topoisomerase
11%
Recombinase
11%
Lymphopoiesis
8%
Immunology and Microbiology
Myeloid
88%
Amino Terminal Sequence
44%
Conditioning
44%
MDS1 and EVI1 Complex Locus Protein
44%
Droplet Digital Polymerase Chain Reaction
44%
Real-Time Polymerase Chain Reaction
24%
Laboratory Test
14%
Hematopoiesis
9%
Lymphopoiesis
8%